Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CAMBRIDGE NUTRITIONAL SCIENCES PLC Board/Management Information 2021

Jul 13, 2021

7544_mang_2021-07-13_2a14d1fa-09d0-4297-988e-d8c379c8bf43.html

Board/Management Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 9964E

Omega Diagnostics Group PLC

13 July 2021

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Directorate Change

Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance testing, announces that Kieron Harbinson, Group Finance Director of the Company, has notified the Board that he will step down from his position after 19 years of service with the Company. The Board would like to thank Kieron for his many years of service and wish him all the luck his future endeavours.

Following a process to identify a replacement, the Company has agreed to appoint Chris Lea, ACA, as Chief Financial Officer. Chris is an experienced public markets CFO, having most recently held the position of Chief Financial Officer at IndigoVision Group plc (AIM: IND) and Finance Director at Superglass Holdings PLC (AIM: SPGH) before that.

Chris qualified as a chartered accountant with KPMG in 1992 and has extensive public company and private equity board level experience gained within multi-national, high growth and turnaround environments. Chris' appointment will be effective as of 30 August 2021.

Colin King, Chief Executive Officer of the Company, said: 

"I would like to personally thank Kieron for all the support and guidance he has provided me since I joined the Company, he has been a great servant to Omega and I wish him all the best in whatever he decides to do in the future.  I would also like to welcome Chris Lea to Omega next month and look forward to working with him on the next phase of Omega's exciting future"

The following information is disclosed about Christopher Paul Lea, age 54, pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies:

Current Directorships / Partnerships Previous Directorships / Partnerships held in the past 5 years
N/A IndigoVision Group Limited (formerly IndigoVision Group  plc)
IndigoVision Limited
IndigoVision UK Limited
IndigoVision Inc
IndigoVision Australia Pty Limited
IndigoVision PTE Ltd
AgoraSys SA
IndigoVision Solucoes de Seguranca Electronica Limitada
IndigoVision Video Security Solutions Limited
IndigoVision Security Systems (Shanghai) Co Ltd

Mr. Lea does not currently hold any ordinary shares in the Company.  There are no other disclosures required in relation to Rule 17 or paragraph (g) of Schedule 2 of the AIM Rules for Companies.

Contacts: 

Omega Diagnostics Group PLC Tel: 01259 763 030
Colin King, Chief Executive www.omegadiagnostics.com
Kieron Harbinson, Group Finance Director
finnCap Ltd Tel: 020 7220 0500
Geoff Nash/ Teddy Whiley (Corporate Finance)
Alice Lane (ECM)
Walbrook PR Limited Tel: 020 7933 8780 or [email protected]
Paul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07584 391 303

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAGPUUWMUPGPPP